Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Methods × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 6 Lung Neoplasms 5 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Papillomavirus Infections 3 Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Smoking Cessation 2 Skin Carcinoma 2 Pain 2 Obesity-Related Malignant Neoplasm 2 Hematologic Neoplasms 2 Breast Carcinoma In Situ 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Tobacco Smoking 1 Smoking 1 Sepsis 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Cancer Liver Metastases 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1

Interventions

Ketorolac 2 Ketamine 2 Dexmedetomidine 2 Acetaminophen 2 engage 8200 1 Yoga 1 Transdermal Patch 1 Transcutaneous Electric Nerve Stimulation 1 Telemedicine 1 Surgical Instruments 1 Saline Solution 1 STAMP-I protocol 1 Ropivacaine 1 Radiofrequency Ablation 1 Palliative Care 1 Oxycodone 1 Methods 1 Magnesium Sulfate 1 Levobupivacaine 1 Ketoprofen 1 High-Energy Shock Waves 1 Epinephrine 1 Electroencephalography 1 Electroacupuncture 1 Dipyrone 1 Cryosurgery 1 Clonidine 1 Capsaicin 1 Botulinum Toxins, Type A 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡